Drug intelligence / Profile preview

human hookworm vaccine

Development stage
Unknown
Lead developer
Sabin Vaccine Institute
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

The **human hookworm vaccine** is an investigational bivalent recombinant protein-subunit vaccine for prevention of *Necator americanus* hookworm infection and its consequences, including intestinal blood loss and iron-deficiency anemia. It contains recombinant *N. americanus* glutathione S-transferase-1 and catalytically inactive *N. americanus* aspartic protease-1 M74, two parasite blood-feeding-pathway enzymes. Administered intramuscularly with Alhydrogel and, in studied formulations, a synthetic Toll-like receptor agonist adjuvant, it is intended to elicit antigen-specific antibodies that impair hookworm blood digestion, development, and survival. The program has been developed by the Sabin Vaccine Institute and collaborators for use in endemic populations, particularly children.

Other names
bivalent human hookworm vaccine
02

Targets

Na-APR-1 (Necator americanus aspartic protease 1)Na-GST-1 (Glutathione S-transferase 1 from Necator americanus)

Beyond the preview

Go deeper on human hookworm vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human hookworm vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call